ASPIRANGE Trademark

Trademark Overview

On Thursday, July 21, 2016, a trademark application was filed for ASPIRANGE with the United States Patent and Trademark Office. The USPTO has given the ASPIRANGE trademark a serial number of 87112079. The federal status of this trademark filing is REGISTERED as of Tuesday, August 14, 2018. This trademark is owned by SALSARULO PHARMA. The ASPIRANGE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, aspirin for the use as an antipyretic, analgesic or hemo-rheologic medication
aspirange

General Information

Serial Number87112079
Word MarkASPIRANGE
Filing DateThursday, July 21, 2016
Status700 - REGISTERED
Status DateTuesday, August 14, 2018
Registration Number5538099
Registration DateTuesday, August 14, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 29, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, aspirin for the use as an antipyretic, analgesic or hemo-rheologic medication

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 27, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSALSARULO PHARMA
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBoulogne-Billancourt 92100
FR
Party NameSALSARULO PHARMA
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBoulogne-Billancourt 92100
FR
Party NameSALSARULO PHARMA
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBoulogne-Billancourt 92100
FR

Trademark Events

Event DateEvent Description
Monday, August 14, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 14, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, May 29, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 29, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 9, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 20, 2018NOTICE OF ALLOWANCE CANCELLED
Thursday, April 5, 2018ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Thursday, April 5, 2018PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Monday, April 2, 2018ASSIGNED TO PETITION STAFF
Tuesday, March 6, 2018TEAS PETITION TO AMEND BASIS RECEIVED
Saturday, November 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 9, 2017SOU EXTENSION 1 GRANTED
Thursday, November 9, 2017SOU EXTENSION 1 FILED
Thursday, November 9, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, May 9, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 9, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, February 2, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 1, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 1, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 25, 2017ASSIGNED TO LIE
Thursday, January 5, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 1, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 1, 2016NON-FINAL ACTION E-MAILED
Tuesday, November 1, 2016NON-FINAL ACTION WRITTEN
Tuesday, November 1, 2016ASSIGNED TO EXAMINER
Wednesday, July 27, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 25, 2016NEW APPLICATION ENTERED

Related Keywords

aspirange hemo rheologic medication analgesic antipyretic preparations namely aspirin pharmaceutical